RUTGERS, THE STATE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean

Phase 4

Completed

Conditions: Nausea
Vomiting
Satisfaction

Interventions: Device: Acupressure Point P6 stimulator
Drug: Metoclopramide
Drug: Ondansetron

First Posted Date: 2016-11-09

Last Posted Date: 2017-09-25

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 180

Registration Number: NCT02959840

Locations: 🇺🇸
Robert Wood Johnson University Hospital, New Brunswick, New Jersey, United States

Androgen Receptor Antagonist ARN-509 With or Without Abiraterone Acetate, Gonadotropin-Releasing Hormone Analog, and Prednisone in Treating Patients With High-Risk Prostate Cancer Undergoing Surgery

Phase 2

Recruiting

Conditions: Stage II Prostate Adenocarcinoma
Stage III Prostate Adenocarcinoma

Interventions: Drug: Abiraterone Acetate
Drug: Androgen Receptor Antagonist ARN-509
Other: Quality-of-Life Assessment
Biological: Gonadotropin-releasing Hormone Analog
Drug: Prednisone
Other: Questionnaire Administration
Procedure: Radical Prostatectomy

First Posted Date: 2016-10-31

Last Posted Date: 2023-09-26

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 90

Registration Number: NCT02949284

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
Yale Cancer Center, New Haven, Connecticut, United States

Measurement of Anterior Chamber Cell Grading Using Ocular Coherence Tomography

Not Applicable

Terminated

Conditions: Uveitis

Interventions: Device: Optical Coherence Tomography (OCT)
Other: Eye Exam

First Posted Date: 2016-09-20

Last Posted Date: 2019-05-06

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 6

Registration Number: NCT02907814

Locations: 🇺🇸
Doctors Office Center, Newark, New Jersey, United States

Enzalutamide Before Surgery in Treating Patients With Kidney Cancer

Early Phase 1

Terminated

Conditions: Stage I Renal Cell Cancer
Clear Cell Renal Cell Carcinoma

Interventions: Drug: Enzalutamide
Other: Laboratory Biomarker Analysis
Procedure: Nephrectomy

First Posted Date: 2016-08-31

Last Posted Date: 2021-09-16

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 3

Registration Number: NCT02885649

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Multi-dose Acetaminophen for Patients Undergoing General Anesthesia

Phase 4

Terminated

Conditions: Recovery Following Cholecystectomy

Interventions: Drug: normal saline
Drug: Acetaminophen

First Posted Date: 2016-07-14

Last Posted Date: 2021-12-09

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 88

Registration Number: NCT02832687

Locations: 🇺🇸
New Jersey Medical School, Newark, New Jersey, United States
🇺🇸
University Hospital, Newark, New Jersey, United States
🇺🇸
New York Methodist Hospital, Brooklyn, New York, United States

Aldesleukin and Pembrolizumab in Treating Patients With Stage III-IV Melanoma

Phase 2

Terminated

Conditions: Stage III Mucosal Melanoma of the Head and Neck
Stage IV Skin Melanoma
Stage IVA Mucosal Melanoma of the Head and Neck
Stage IVB Mucosal Melanoma of the Head and Neck
Metastatic Melanoma
Stage IIIA Skin Melanoma
Stage IVC Mucosal Melanoma of the Head and Neck
Stage IIIB Skin Melanoma
Stage IIIC Skin Melanoma

Interventions: Biological: Aldesleukin
Other: Laboratory Biomarker Analysis
Biological: Pembrolizumab

First Posted Date: 2016-04-22

Last Posted Date: 2023-08-03

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 10

Registration Number: NCT02748564

Locations: 🇺🇸
Cardinal Bernardin Cancer Center, Maywood, Illinois, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
Indiana University, Bloomington, Indiana, United States

and more 2 locations

Improving The Safety And Nutritional Adequacy Of The Home Food Supply Of Elderly Recipients Of Home Delivered Meals

Completed

Conditions: Frail Elderly
Food Safety
Nutritive Value
Homebound Persons

First Posted Date: 2016-03-25

Last Posted Date: 2016-03-25

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 740

Registration Number: NCT02719626

Locations: 🇺🇸
St. Vincent's Meals on Wheels, Los Angeles, California, United States
🇺🇸
CareLink, Little Rock, Arkansas, United States
🇺🇸
The Heritage Agency on Aging, Cedar Rapids, Iowa, United States

and more 4 locations

eHealth Weight Loss Program in African American Breast Cancer Survivors

Not Applicable

Completed

Conditions: Stage IIIA Breast Cancer
Cancer Survivor
Stage IIA Breast Cancer
Stage IIIB Breast Cancer
Stage IB Breast Cancer
Stage IIIC Breast Cancer
Stage IA Breast Cancer
Stage IIB Breast Cancer
Stage 0 Breast Cancer

Interventions: Device: Activity Monitoring Device
Behavioral: Behavioral Dietary Intervention
Behavioral: Exercise Intervention

First Posted Date: 2016-03-07

Last Posted Date: 2021-04-13

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 35

Registration Number: NCT02699983

Locations: 🇺🇸
Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States

Peer Mentoring in Promoting Follow-up Care Self-Management in Younger Childhood Cancer Survivors

Not Applicable

Completed

Conditions: Cancer Survivor

Interventions: Other: Questionnaire Administration
Behavioral: Telephone-Based Intervention

First Posted Date: 2016-03-07

Last Posted Date: 2022-10-19

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 31

Registration Number: NCT02699996

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States

Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer

Recruiting

Conditions: Malignant Neoplasm

Interventions: Other: Cytology Specimen Collection Procedure
Other: Laboratory Biomarker Analysis

First Posted Date: 2016-02-23

Last Posted Date: 2023-08-07

Lead Sponsor: Rutgers, The State University of New Jersey

Target Recruit Count: 1100

Registration Number: NCT02688517

Locations: 🇺🇸
Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, United States
🇺🇸
Riverview Medical Center, Red Bank, New Jersey, United States
🇺🇸
Bayshore Community Hospital, Holmdel, New Jersey, United States

and more 8 locations

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy